Chase Knickerbocker

Chase Knickerbocker Analyst Performance

Senior Equity Research Analyst - Healthcare at Craig Hallum

Chase Knickerbocker is a stock analyst at Craig Hallum focused in the healthcare sector, covering 24 publicly traded companies. Over the past year, Chase Knickerbocker has issued 18 stock ratings, including and buy recommendations. While full access to Chase Knickerbocker's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Chase Knickerbocker's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
51 Last 2 Years
Buy Recommendations
98.00% 49 Buy Ratings
Companies Covered
24 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy2.0%1 ratings
Buy96.0%48 ratings
Hold2.0%1 ratings
Sell0.0%0 ratings

Out of 50 total stock ratings issued by Chase Knickerbocker at Craig Hallum, the majority (96.0%) have been Buy recommendations, followed by 2.0% Strong Buy and 2.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
83.3% of companies on NASDAQ
20 companies
NYSEAMERICAN
8.3% of companies on NYSEAMERICAN
2 companies
OTCMKTS
4.2% of companies on OTCMKTS
1 company
NYSE
4.2% of companies on NYSE
1 company

Chase Knickerbocker, an analyst at Craig Hallum, currently covers 24 companies listed on NASDAQ, NYSEAMERICAN, OTCMKTS and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
23 companies
95.8%
Real Estate
1 company
4.2%

Chase Knickerbocker of Craig Hallum specializes in stock coverage within the Healthcare sector, with additional focus on Real Estate companies.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
9 companies
37.5%
HEALTHCARE EQUIPMENT & SUPPLIES
9 companies
37.5%
BIOTECHNOLOGY
5 companies
20.8%
REAL ESTATE MANAGEMENT & DEVELOPMENT
1 company
4.2%

About Chase Knickerbocker

Chase focuses on Specialty Pharmaceutical, Biotech, and Medical Technology companies. He brings a unique commercial perspective to his coverage, as he held several field sales roles at Stryker earlier in his career, prior to joining Craig-Hallum. Chase received his BA in Finance from the University of Minnesota Crookston.
Follow on LinkedIn

Chase Knickerbocker's Ratings History at Craig Hallum

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
10/21/2026Reiterated Rating$7.13$15.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
10/19/2026Set Price Target$1.46$5.00
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
10/15/2026Reiterated Rating$54.67$78.00Buy
TELA Bio, Inc. stock logo
TELA
TELA Bio
9/25/2026Initiated Coverage$1.27$2.00Buy
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
8/27/2026Boost Price Target$4.54$8.00Buy
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
8/14/2026Reiterated Rating$8.78$17.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
7/28/2026Boost Price Target$44.85$62.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
7/1/2026Initiated Coverage$9.53$48.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
7/1/2026Initiated Coverage$9.44$48.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
6/3/2026Lower Price Target$86.83$171.00Buy
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
4/17/2026Initiated Coverage$6.65$14.00Buy
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
4/17/2026Lower Price Target$3.44$7.00Buy
NeurAxis, Inc. stock logo
NRXS
NeurAxis
3/20/2026Boost Price Target$7.69$13.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/20/2026Boost Price Target$22.55$35.00Buy
Myomo, Inc. stock logo
MYO
Myomo
3/10/2026Reiterated Rating$0.70Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/3/2026Boost Price Target$17.49$30.00Buy
Indivior PLC stock logo
INVVY
Indivior
1/9/2026Reiterated Rating$21.85$50.00Buy
NeurAxis, Inc. stock logo
NRXS
NeurAxis
12/22/2025Boost Price Target$3.39$8.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
10/31/2025Reiterated Rating$13.73$22.00Buy
Indivior PLC stock logo
INDV
Indivior
10/31/2025Reiterated Rating$29.58$41.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
10/21/2025Reiterated Rating$11.45$20.00Buy
Harrow, Inc. stock logo
HROW
Harrow
9/23/2025Boost Price Target$49.35$64.00Buy
Indivior PLC stock logo
INDV
Indivior
8/27/2025Boost Price Target$24.53$34.00Buy
Adherex Technologies Inc. stock logo
FENC
Adherex Technologies
8/15/2025Boost Price Target$8.55$14.00Buy
PolyPid Ltd. stock logo
PYPD
PolyPid
8/14/2025Reiterated Rating$3.41$13.00Buy
DiaMedica Therapeutics, Inc. stock logo
DMAC
DiaMedica Therapeutics
7/18/2025Boost Price Target$3.93$11.00Buy
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
7/1/2025Initiated Coverage$2.00$3.00Buy
Indivior PLC stock logo
INDV
Indivior
6/30/2025Boost Price Target$13.95$22.00Buy
Myomo, Inc. stock logo
MYO
Myomo
6/23/2025Set Price Target$2.23$8.00Buy
NeurAxis, Inc. stock logo
NRXS
NeurAxis
6/16/2025Initiated Coverage$2.54Buy
NeurAxis, Inc. stock logo
NRXS
NeurAxis
6/16/2025Upgrade$2.58$7.00Strong-Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
6/9/2025Boost Price Target$8.73$17.00Buy
Adherex Technologies Inc. stock logo
FENC
Adherex Technologies
5/14/2025Boost Price Target$6.51$13.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
5/14/2025Boost Price Target$17.09$28.00Buy
Myomo, Inc. stock logo
MYO
Myomo
5/8/2025Lower Price Target$3.40$10.00Buy
Bioventus Inc. stock logo
BVS
Bioventus
5/7/2025Set Price Target$6.55$15.00Buy
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
4/16/2025Downgrade$0.73Hold
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/19/2025Boost Price Target$14.70$26.00Buy
Myomo, Inc. stock logo
MYO
Myomo
3/11/2025Boost Price Target$5.69$11.00Buy
Xeris Biopharma Holdings, Inc. stock logo
XERS
Xeris Biopharma
3/7/2025Boost Price Target$4.24$6.50Buy
URGENT: If you own a home, please review the map below. (Ad)

More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.tc pixel

See the map and get the full details on what this means for you
CoStar Group, Inc. stock logo
CSGP
CoStar Group
2/28/2025Initiated Coverage$76.25Buy
MediWound Ltd. stock logo
MDWD
MediWound
2/28/2025Initiated Coverage$16.23$39.00Buy
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
1/22/2025Lower Price Target$3.79$8.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
1/17/2025Boost Price Target$13.98$21.00Buy
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
1/17/2025Boost Price Target$4.15$6.00Buy
Myomo, Inc. stock logo
MYO
Myomo
12/13/2024Boost Price Target$6.35$9.00Buy